Drug recall · November 4, 2020
Catapres recall
Why: An extraneous peak was observed for dissolution testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0006-01
- Lots / codes
Lot # 761544, 859015, EXP Jan 2021, 861346, 956626, EXP Jan 2022
- Quantity
- 13,270 bottles/100 tablets each
- Company
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
- Distribution
- Distributed Nationwide in the USA and Puerto Rico
- Initiated
- October 5, 2020 · Voluntary: Firm initiated
- Classified
- October 26, 2020
- Reported
- November 4, 2020
- Ended
- September 29, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.